Bicara Therapeutics Inc. Common Stock
BCAXBicara Therapeutics Inc. (BCAX) is a biotechnology company focused on developing innovative immuno-oncology therapies. The company specializes in creating targeted treatments that modulate the immune system to combat cancer, leveraging its proprietary platform to develop novel antibody-based therapies.
Company News
Oncology drug delivery is advancing through nanomedicine technologies, with companies developing innovative platforms to improve drug bioavailability, reduce toxicity, and enhance therapeutic effectiveness in cancer treatments.
Bicara Therapeutics presented updated data from its Phase 1/1b clinical trial of ficerafusp alfa in combination with pembrolizumab in patients with first-line recurrent/metastatic head and neck squamous cell carcinoma (HNSCC). The data showed deep and durable responses, with a median duration of response of 21.7 months and a median overall surviv...
